ERBAMONT INC. – Trademark Portfolio
Entity Type: 03
ERBAMONT INC. holds 79 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 72 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include EMETROL, VINCASAR, ZINECARD, MYCOBUTIN, and MAG-TAB SR. The owner is based in DUBLIN, OH.
7001 POST ROAD
DUBLIN, OH
Showing of trademarks Trademarks
Trademark Classifications
ERBAMONT INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does ERBAMONT INC. have?
ERBAMONT INC. has 79 U.S. trademarks filed with the USPTO. Of these, 6 registered, 12 abandoned, 61 cancelled.
What trademark classes does ERBAMONT INC. file in?
ERBAMONT INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ERBAMONT INC.'s most well-known trademarks?
ERBAMONT INC.'s registered trademark portfolio includes well-known marks such as EMETROL, VINCASAR, ZINECARD, MYCOBUTIN, and MAG-TAB SR. These are among 6 currently registered trademarks in the portfolio.
What is ERBAMONT INC.'s trademark registration success rate?
ERBAMONT INC. has a 8% trademark registration rate, with 6 out of 79 resolved applications resulting in successful registration. Currently, 0 applications are pending review.